SLC2A2 and cancer: This filtering step narrowed down the previous list of genes to two, SLC2A2 (P = 2.3 × 10-5) targeted by the anti-cancer drug streptozotocin (US brand name Zanosar®, not available in Switzerland) and KCNJ13 (P = 0.0001) targeted by fampridine (Swiss brand name Fampyra®), see also Supplementary Dataset 1 for detailed SNP association results.